Individuals Institutional

Call toll-free 800.328.1267

Market Insights

Bringing you the trading news around the world.

This Handful of Stocks Rose Despite Yesterday's Carnage
A Handful of Stocks Just Rose Despite Yesterday’s Carnage
David Russell
February 26, 2020

The S&P 500 got hammered yesterday, but a handful of stocks shot higher on good news. Here are their stories.

HP (HPQ) and Xerox (XRX) had the biggest gains in the index as their takeover battles continue. It all started in November when XRX offered to buy HPQ for a 20 percent premium.

The computer maker leaped on the news and began a steady climb. XRX raised its bid on February 10. It then reported strong earnings on Monday night and CEO Enrique Lores suggested he might turn the tables by making a bid for the photocopier firm.

Either way, the developments make some kind of merger seem more likely. Regardless of who buys whom, such a deal would result in billions of cost savings and less competition in the printer market. It would also free up billions for share buybacks.

HP (HPQ), with 50- and 200-day moving averages. Notice recent "golden cross."
HP (HPQ), with 50- and 200-day moving averages. Notice recent “golden cross.”

The result? HPQ rose 6 percent and XRX gained 5 percent. Not bad on a day when the S&P 500 dropped 3 percent to its lowest level since December 5. In fact, it’s worse than that because if you include Monday’s selloff, the market is now in the midst of its worst two-day slide since August 2015.

Regeneron Rallies

Regeneron Pharmaceuticals (REGN) had the third-biggest gain in the S&P 500. The drug maker rallied 4 percent after rival Novartis (NVS) launched a safety review of its blindness treatment Beovu. Wall Street viewed that as good news for REGN’s macular degeneration drug, Eylea.

Keysight Technologies (KEYS) followed with a 3 percent gain after earnings and revenue beat estimates. This company is a provider of technology for 5G networking, which is expected to receive over $1 trillion of investment in the next five years.

Regeneron Pharmaceuticals (REGN), with 50- and 200-day moving averages. Notice recent “golden cross.”

Perrigo (PRGO) was the fifth member of the S&P 500 to gain at least 1 percent yesterday. It jumped 3 percent after the Food and Drug Administration approved one of its respiratory drugs.

In conclusion, coronavirus worries have dragged the market lower. But a few companies swam against the bearish tide. Investors may want to keep an eye on these names when things begin to calm down.

Tags: HPQ | KEYS | PRGO | REGN | XRX

About the author

David Russell is Global Head of Market Strategy at TradeStation. Drawing on nearly two decades of experience as a financial journalist and analyst, his background includes equities, emerging markets, fixed-income and derivatives. He previously worked at Bloomberg News, CNBC and E*TRADE Financial. Russell systematically reviews countless global financial headlines and indicators in search of broad tradable trends that present opportunities repeatedly over time. Customers can expect him to keep them appraised of sector leadership, relative strength and the big stories – especially those overlooked by other commentators. He’s also a big fan of generating leverage with options to limit capital at risk.